Construct: ORF TRCN0000487708
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF021735.1_s317c1
- DNA Barcode:
- AAGTTCAAGTCTTTTTGTAGGCCG
- Epitope Tag:
- V5 (not translated due to prior stop codon)
- Notes:
- Has stop codon in insert
Originally Annotated References:
- Gene:
- FGFR2 (2263)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000487708
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447892.1 | 89% | 89% | 1_141del |
2 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001320654.1 | 64.7% | 64.7% | 1_627del |
3 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144918.2 | 54.5% | 54.5% | 1_960del |
4 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144917.2 | 54.4% | 54.4% | 1_963del |
5 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144916.1 | 54.3% | 54.3% | 1_966del |
6 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144914.1 | 54.1% | 54.1% | 1_975del |
7 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015924.2 | 52.9% | 52.9% | 1_1023del |
8 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447891.1 | 52.8% | 52.8% | 1_1026del |
9 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_023029.2 | 52.4% | 52.4% | 1_1044del |
10 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447889.1 | 51.2% | 51.2% | 1_1095del |
11 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447888.1 | 51.2% | 51.2% | 1_1098del |
12 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447887.1 | 51.1% | 51.1% | 1_1101del |
13 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447890.1 | 51% | 51% | 1_1104del |
14 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015925.2 | 48.1% | 47.9% | (many diffs) |
15 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144915.1 | 47.3% | 45.7% | (many diffs) |
16 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001320658.2 | 46.8% | 46.8% | 1_1305del |
17 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_000141.4 | 46.7% | 46.7% | 1_1311del |
18 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_022970.3 | 46.7% | 46.7% | 1_1314del |
19 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_006717708.3 | 45.7% | 45.7% | 1_1365del |
20 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144919.2 | 45.1% | 45% | 1_1047del;2037_2038insGA;2040_2040delCins158 |
21 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015921.2 | 41.5% | 41.4% | (many diffs) |
22 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015920.2 | 41.4% | 41.3% | (many diffs) |
23 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_006717710.4 | 41.3% | 41.2% | (many diffs) |
24 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144913.1 | 40.2% | 40.1% | 1_1314del;2304_2305insGA;2307_2307delCins158 |
25 | human | 2263 | FGFR2 | fibroblast growth factor re... | NR_073009.2 | 26% | 1_1747del;2900_4427del | |
26 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_001347638.1 | 48.4% | 52.8% | (many diffs) |
27 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241677.2 | 48.3% | 52.7% | (many diffs) |
28 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507357.3 | 48.3% | 52.6% | (many diffs) |
29 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_201601.2 | 48.2% | 52.6% | (many diffs) |
30 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241676.2 | 46.7% | 50.9% | (many diffs) |
31 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241675.2 | 46.6% | 50.8% | (many diffs) |
32 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507354.3 | 46.5% | 50.7% | (many diffs) |
33 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241674.2 | 41.8% | 45.5% | (many diffs) |
34 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507350.3 | 41.7% | 45.5% | (many diffs) |
35 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_010207.2 | 41.7% | 45.4% | (many diffs) |
36 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507349.2 | 41.6% | 45.4% | (many diffs) |
37 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241673.2 | 41.6% | 45.4% | (many diffs) |
38 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321975.1 | 41.6% | 45.4% | (many diffs) |
39 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321977.1 | 38% | 41.2% | (many diffs) |
40 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321976.1 | 37.9% | 41.2% | (many diffs) |
41 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507352.2 | 37.8% | 41.1% | (many diffs) |
42 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XR_001785477.1 | 15.7% | (many diffs) | |
43 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XR_001785478.1 | 15.5% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 153
- ORF end:
- 1305
- ORF length:
- 1152
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 caggcttcag cagccagccg gctgtgcaca agctgaccaa acgtatcccc ctgcggagac 121 aggtaacagt ttcggctgag tccagctcct ccatgaactc caacaccccg ctggtgagga 181 taacaacacg cctctcttca acggcagaca cccccatgct ggcaggggtc tccgagtatg 241 aacttccaga ggacccaaaa tgggagtttc caagagataa gctgacactg ggcaagcccc 301 tgggagaagg ttgctttggg caagtggtca tggcggaagc agtgggaatt gacaaagaca 361 agcccaagga ggcggtcacc gtggccgtga agatgttgaa agatgatgcc acagagaaag 421 acctttctga tctggtgtca gagatggaga tgatgaagat gattgggaaa cacaagaata 481 tcataaatct tcttggagcc tgcacacagg atgggcctct ctatgtcata gttgagtatg 541 cctctaaagg caacctccga gaatacctcc gagcccggag gccacccggg atggagtact 601 cctatgacat taaccgtgtt cctgaggagc agatgacctt caaggacttg gtgtcatgca 661 cctaccagct ggccagaggc atggagtact tggcttccca aaaatgtatt catcgagatt 721 tagcagccag aaatgttttg gtaacagaaa acaatgtgat gaaaatagca gactttggac 781 tcgccagaga tatcaacaat atagactatt acaaaaagac caccaatggg cggcttccag 841 tcaagtggat ggctccagaa gccctgtttg atagagtata cactcatcag agtgatgtct 901 ggtccttcgg ggtgttaatg tgggagatct tcactttagg gggctcgccc tacccaggga 961 ttcccgtgga ggaacttttt aagctgctga aggaaggaca cagaatggat aagccagcca 1021 actgcaccaa cgaactgtac atgatgatga gggactgttg gcatgcagtg ccctcccaga 1081 gaccaacgtt caagcagttg gtagaagact tggatcgaaT TCTCACTCTC ACAACCAATG 1141 AGGAATACTT GGACCTCAGC CAACCTCTCG AACAGTATTC ACCTAGTTAC CCTGACACAA 1201 GAAGTTCTTG TTCTTCAGGA GATGATTCTG TTTTTTCTCC AGACCCCATG CCTTACGAAC 1261 CATGCCTTCC TCAGTATCCA CACATAAACG GCAGTGTTAA AACATGAGAC CCAGCTTTCT 1321 TGTACAAAGT GGTTGATATC GGTAAGCCTA TCCCTAACCC TCTCCTCGGT CTCGATTCTA 1381 CGTAGTAATG AACTAGTCCG TAACTTGAAA GTATTTCGAT TTCTTGGCTT TATATATCTT 1441 GTGGAAAGGA CGAAAGTTCA AGTCTTTTTG TAGGCCGACG CGTTAAGTCg acaatcaacc 1501 tctggattac aaaatttgtg aaagatt